Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07685028 · ClinicalTrials.gov registry record · NA
LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol A
A NA study, sponsored by Massachusetts General Hospital.
- Not yet
- Registry status
- NA
- Development phase
- 250
- Enrollment target
NCT07685028: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT07685028 is a NA study that has not yet begun recruiting, run by Massachusetts General Hospital. The registered enrollment target is 250 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07685028, a NA study, has not yet begun recruiting, sponsored by Massachusetts General Hospital.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
Study Summary
This research is being done to determine if an image-based deep learning model (Sybil) can accurately predict the likelihood of future lung cancer based on chest computed tomography (CT) imaging from individuals.
Interventions
- DIAGNOSTIC_TEST CT scan
- OTHER Sybil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2026-10-06 |
| Est. Completion | 2035-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07685028
The ClinicalTrials.gov registry entry for NCT07685028 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CT scan is the first listed.
NCT07685028 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07685028 about?
NCT07685028 is a clinical study titled "LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol A". This research is being done to determine if an image-based deep learning model (Sybil) can accurately predict the likelihood of future lung cancer based on chest computed tomography (CT) imaging from individuals.
What is the current status of trial NCT07685028?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2026-10-06. Estimated completion is 2035-12-31.
What interventions are being tested in trial NCT07685028?
The interventions under investigation include: CT scan (DIAGNOSTIC_TEST), Sybil (OTHER).
Who is sponsoring clinical trial NCT07685028?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.